Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Tang Carolyn C. | CA | O | GC | 1 | S.m | -318 | 22.01 | 0 | -14 | 125 | D | |||||||||||||||
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Markus Richard | CA | O | Chief Me | 1 | S.m | -210 | 22.01 | 0 | -10 | 66 | D | |||||||||||||||
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Azoy Alexander | CA | O | Chief Ac | 3 | S.dm | -282 | 20.77 | 0 | -14 | 27 | D | |||||||||||||||
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | 3 | S.m | -504 | 22.23 | 0 | -23 | 92 | D | |||||||||||||||
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Jarrett Jennifer | CA | O | COO | 3 | S.dm | -2,171 | 17.83 | 0 | -122 | 214 | D | |||||||||||||||
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Jaen Juan C. | CA | O | P | 5 | S.m | -5,628 | 22.04 | 0 | -255 | 1,459 | D | |||||||||||||||
12/18/25 17:35 | 12/16/25 | RCUS | Health | Drug | Pharmaceutical Preparations | Rosen Terry J | CA | DO | CEO | 1 | S.m | -1,204 | 22.01 | 0 | -55 | 2,195 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |